Pfizer and BioNTech stopped a major study of their updated COVID-19 vaccine in healthy adults aged 50–64 because too few participants enrolled — reflecting current low demand and shifting epidemiology.
🔗
https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-halt-us-covid-vaccine-study-after-recruitment-struggles-2026-04-01/
#HealthNews 🌿
